NMC Issues Updated Professional Conduct & Practice Regulations 2026

The National Medical Commission (NMC) has formally released the updated Registered Medical Practitioners (Professional Conduct) Regulations, 2026, introducing significant reforms aimed at aligning medical ethics with contemporary digital healthcare practices, strict transparency in prescription practices, and rigorous oversight over professional advertising.

Key Highlights of the 2026 Guidelines

1. Mandatory Generic Prescriptions and Legibility

The updated regulations strictly mandate that all Registered Medical Practitioners (RMPs) must prescribe medications using generic names legibly, preferably utilizing electronic health record (EHR) systems or printed prescriptions.

Exceptions: Rational combination medications that cannot be uniquely described by generic ingredients alone must include exact biochemical compositions.
Penalties for Non-Compliance: Repeated issuance of illegible or brand-driven prescriptions without clinical justification may result in mandatory continuous medical education (CME) or temporary suspension of registration for up to 30 days.

2. Digital Health & Telemedicine Protocol Enforcement

Recognizing the rapid expansion of tele-consultations across India, the NMC has updated the mandatory protocols for remote medical consultations:

Identity Verification: Doctors must verify patient identity via government-issued identity documents prior to issuing initial prescriptions for Schedule H and H1 drugs via telemedicine.
Digital Consent Documentation: Explicit digital consent (either recorded verbal or secure electronic signature) must be preserved in patient health records for a minimum period of three years.

3. Social Media & Online Advertising Ethics

To combat unethical self-promotion and misleading healthcare claims, the regulations introduce clear boundaries for medical practitioners on digital platforms:

Endorsements Prohibited: RMPs are strictly prohibited from endorsing commercial health products, nutraceuticals, or medical devices on personal or professional social media handles.
Before-and-After Clinical Imagery: Patient before-and-after photographs may only be displayed for academic education or scientific journals, and cannot be utilized as promotional marketing material on public portals.

Practical Recommendations for Healthcare Providers

To maintain seamless compliance and mitigate regulatory risks under the new framework, practitioners and clinical directors should immediately take the following action steps:

Upgrade Prescription Systems: Transition outpatient clinics to digital electronic prescription software that automatically populates generic drug nomenclature.
Review Practice Marketing: Conduct a thorough audit of hospital websites, clinic brochures, and social media channels to purge any testimonials or guarantees of cure.
Staff Training: Conduct orientation briefings for resident doctors and nursing staff regarding secure telemedicine consent logging and data privacy compliance under the Digital Personal Data Protection (DPDP) standards.

MedicoLegalAid Commentary

The 2026 regulations demonstrate the NMC's unwavering commitment to patient rights and clinical transparency. While transition to electronic generic prescribing may introduce short-term operational hurdles for solo practitioners, proactive adaptation protects clinicians from statutory disciplinary actions by State Medical Councils.